Abstract
The mechanism by which exposure to the industrial solvent benzene (BZ) can result in aplastic anemia or leukemia (see Snyder and Kalf, 1994 for review) has been under intensive investigation. Topoisomerase (topo) II inhibitors are used clinically as cancer chemotherapeutic agents and can also lead to secondary AML (see Felix, 1998; Leone et al., 1999 for review). Hydroquinone (HQ), a hematotoxic metabolite of BZ, has been shown to inhibit purified human topo II (Hutt and Kalf, 1996; Frantz et al., 1996). It has therefore been suggested that some of the hematotoxic effects of BZ may be mediated by the ability of some of its metabolites to inhibit topo II activity (Whysner, 2000). In the studies presented here a normal, IL-3 dependent mouse myeloblast cell line (32D.3 (G)) was used to determine whether the hematotoxic effects of BZ may result from inhibition of topo II by HQ. The 32D.3 (G) myeloblasts undergo differentiation and maturation to neutrophils upon treatment with the physiological inducer, granulocyte colony-stimulating factor (G-CSF) (Metcalf, 1985; Valtieri et al., 1987). In this system HQ treatment inhibits apoptosis, induces differentiation of myeloblasts to the myelocyte stage, and blocks maturation to the neutrophil (Hazel et al., 1995), a series of events similar to those observed in AML, which is characterized by clonal expansion of immature granulocytes (Lowenberg and Delwel, 1991). There is evidence linking topo II activity to differentiation and maturation in the HL-60, human leukemia cell line. In this system 3-nitrobenzothiazolo[3,2-a]quinolinium, an inhibitor of topo II activity, has been shown to induce incomplete myeloid differentiation (Baez and Sepulveda, 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baez, A. and Sepulveda, J.(1992).Myeloid differentiation of HL-60 cells induced by anti-tumor drug 3nitrobenzothiazolo[3,2-a]quinolinium. Leulc Res. 16 363–370.
Felix, C.A. (1998). Secondary leukemia induced by topoisomerase-targeted drugs. Biochim. Biophys. 1400 233–255.
Frantz, C.E., Chen, H., and Eastmond, D.A.(1996).Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ. Health Perspect. 104 1319–1323.
Hazel, B.A., O’Conner, A., Nicolescu R.,and Kalf, G.F. (1995). Benzene and its metabolite, hydroquinone, induce granulocytic differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor. Stem Cells 13 295–310.
Hutt, A.M. and Kalf, G.F. (1996). Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. Environ. Health Perspect. 104 1261–1269.
Kaufmann, S.H., McLaughlin, S.J., Kastan, M.B., Liu, L.F., Karp, J.E., and Burke, P.J. (1991).Topoisomerase II levels during granulocytic maturation in vitro and in vivo. Can. Res. 51 3534–3543.
Leone, G., Mele, L., Pulsoni, A., Equitani, F. and Pagano, L. (1999). The incidence of secondary leukemias. Haematologica 84 937–945.
Lowenberg, B. and Delwel, F.R. (1991). The pathology of human acute myeloid leukemia, In: Hematology, Basic Principles and Practice Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., and Cohen, H.J. (eds.) Churchill Livingstone, New York, pp. 708–715.
Metcalf, D. (1985). Multi-CSF-dependent colony formation by cells of a murine hematopoietic cell line: specificity and action of multi-CSF. Blood 65 357–362.
Snyder, R. and Kalf, G.F. (1994). A perspective on benzene leukemogenesis. Crit. Rev. Toxicol. 24 177–209.
Valtieri, M., Tweardy, D.J., Caracciolo, D., Johnson, K., Mavilio, F., Altmann, S., Santoli, D., and Rouera, G. (1987). Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J. Immunol. 138 3829–3835.
Whysner, J. (2000). Benzene-induced genotoxicity. J Toxicol. Environ. Health (in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hoffmann, M.J., Kim, D.D., Akbar, M.G.K., Kalf, G.F., Snyder, R. (2001). The Potential Role of Topoisomerase II Inhibition in Hydroquinone-Induced Alterations in the Maturation of Mouse Myeloblasts. In: Dansette, P.M., et al. Biological Reactive Intermediates VI. Advances in Experimental Medicine and Biology, vol 500. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0667-6_48
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0667-6_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5185-6
Online ISBN: 978-1-4615-0667-6
eBook Packages: Springer Book Archive